Georgia's Online Cancer Information Center

Comparing Community Practice Data in Georgia with the South and U.S.

James Hamrick, MD, MPH, Senior Medical Director, Flatiron Health

An analysis of national Flatiron data from more than 270 community practices, seven of which are in Georgia, highlights trends in community cancer care in the seven weeks beginning March 16, 2020. While cancer patients and community practices are being severely impacted by COVID-19, practices are adapting rapidly and continue to deliver care in unprecedented circumstances. Notably, when CMS announced that telemedicine visits would be billable on parity with office visits, practices in Georgia immediately implemented telemedicine to enable access to care in the context of social distancing.

However, data reveal that total visits, new patient visits, and non-chemotherapy visits went down across the country, in the south, and in Georgia while chemotherapy visits went up marginally overall. Of note, chemotherapy visits dropped then rebounded, indicating that despite being essential, these services were also impacted by COVID-19.

These trends may be indicative of delays in diagnosis and care, as well as potentially worsening cancer outcomes for patients. In spite of their remarkable adaptation in the midst of a pandemic, oncology practices are being challenged by decreases in patient visits and delays in care which may impact their viability. It remains to be seen how and when patients who have experienced delays in diagnosis and access to care will re-enter the system, and which groups will be most impacted in terms of overall outcomes.

Baseline comparison data through May 4, 2020:

Total Visits US down 16%; South down 9%; Georgia down 13%
New Patient Visits US down 35%; South down 29%; Georgia down 23%
Chemo Visits US up 1%; South up 7%; Georgia up 3%
Non Chemo Visits US down 16%; South down 9%; Georgia down 15%


                           
             
                              
 

 

 

*The above data are sourced from over 270 community oncology practices that use Flatiron’s OncoEMR® platform. The data may not be fully representative of Flatiron’s research grade datasets and should only be considered directional.  ©Flatiron Health 2020

Media, News & Events

Despite pandemic, Georgia’s Colorectal Cancer Control Program making significant strides

Thanks to funding awarded by the Centers for Disease Control for five-years beginning July 2020, Georgia CORE and Augusta University are partners in the Georgia Colorectal Cancer Control Program, which is increasing CRC screenings in southeast and southwest Georgia.

3/23/2021

Chasing Cancer with Otis Brawley, MD & Ezekiel J. Emanuel, MD

Otis Brawley says he thinks coronavirus vaccine should be mandated like other vaccines in the U.S.

8/03/2021

Chasing Cancer with Otis Brawley, MD & Ezekiel J. Emanuel, MD

Otis Brawley says he thinks coronavirus vaccine should be mandated like other vaccines in the U.S.

8/03/2021

Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).

6/29/2021

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofitthat leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.